− Arrowhead is eligible to receive up to $1.04B including an upfront payment of $300M and potential development, regulatory and commercial milestones up to $740M − Investigational medicine ARO-AAT to ...
AAT Bioquest is a US-based bioreagents company that specializes in assay technologies. AAT Bioquest's reliable, high performance products enable life science researchers to better understand ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback